Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 1—January 2014
Research

Population-based Surveillance for Bacterial Meningitis in China, September 2006–December 2009

Yixing Li1, Zundong Yin1, Zhujun Shao1, Manshi Li, Xiaofeng Liang, Hardeep S. Sandhu, Stephen C. Hadler, Junhong Li, Yinqi Sun, Jing Li, Wenjing Zou, Mei Lin, Shuyan Zuo, Leonard W. Mayer, Ryan T. Novak, Bingqing Zhu, Li Xu, Huiming LuoComments to Author , and the Acute Meningitis and Encephalitis Syndrome Study Group
Author affiliations: Chinese Center for Disease Control and Prevention, Beijing, China (Y. Li, Z. Yin, X. Liang, J. Li, H. Luo ); National Institute for Communicable Disease Control and Prevention, Beijing (Z. Shao); Shandong Provincial Center for Disease Control and Prevention, Jinan, China (M. Li); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (H.S. Sandhu, S.C. Hadler, L.W. Mayer, R.T. Novak); Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, China (Y. Sun, J. Li); Hubei Provincial Center for Disease Control and Prevention, Wuhan, China (W. Zou); Guangxi Zhuang Autonomous Regional Center for Disease Control and Prevention, Nanning, China (M. Lin); World Health Organization China Office, Beijing (S. Zuo); State Key Laboratory for Infectious Disease Prevention and Control, Beijing, China (B. Zhu, L. Xu )

Main Article

Table 2

Demographic features and bacterial laboratory testing for AMES case-patients in sentinel hospitals in 4 China prefectures, September 2006–December 2009*

Age, sex, and laboratory testing for case-patients No. (%) patients by province/prefecture
 Total no (%), n = 4,712
Shandong/Jinan, n = 1,200 Hubei/Yichang n = 1,055 Hebei/Shijiazhuang, n = 959 Guangxi/Guigang, n = 1,498
Case-patient age, y
<2 152 (12.7) 85 (8.1) 232 (24.2) 387 (25.8) 856 (18.2)
2–4 233 (19.4) 89 (8.4) 169 (17.6) 295 (19.7) 786 (16.7)
5–14 393 (32.8) 271 (25.7) 383 (39.9) 380 (25.4) 1,427 (30.3)
15–29 170 (14.2) 189 (17.9) 86 (9.0) 110 (7.3) 555 (11.8)
30–44 135 (11.3) 197 (18.7) 33 (3.4) 88 (5.9) 453 (9.6)
>45
 117 (9.8)
 224 (21.2)
 56 (5.8)
 238 (15.9)
 635 (13.5)
Case-patient sex
M 741 (61.8) 642 (60.9) 586 (61.1) 936 (62.5) 2,905 (61.7)
F
 459 (38.3)
 413 (39.1)
 373 (38.9)
 562 (37.5)
 1,807 (38.3)
Case-patient specimen testing
CSF examination 1,007 (83.9) 751 (71.2) 575 (60.0) 1,131 (75.5) 3,464 (73.5)
Blood, first culture 26 (2.2) 507 (48.1) 311 (32.4) 662 (44.2) 1,506 (32.0)
CSF culture 250 (20.8) 567 (53.7) 345 (36.0) 754 (50.3) 1,916 (40.7)
CSF latex agglutination 80 (6.7) 282 (26.7) 95 (9.9) 286 (19.1) 743 (15.8)
CSF real-time PCR 721 (60.1) 540 (51.2) 131 (13.7) 407 (27.2) 1,799 (38.2)
Any testing method
 851 (70.9)
 834 (79.1)
 563 (58.7)
 1,143 (76.3)
 3,391 (72.0)
No. case-patients positive for Japanese encephalitis virus 136 29 20 111 296

*AMES, acute meningitis and encephalitis syndrome; CSF, cerebrospinal fluid.

Main Article

1These authors contributed equally to this article.

2Members of the Acute Meningitis and Encephalitis Syndrome Study Group are listed at the end of this article.

Page created: January 03, 2014
Page updated: January 03, 2014
Page reviewed: January 03, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external